None

Oncology Clinical Trials Congress And Oncology Clinical Trials In Emerging Regions, 13-14 May 2013, Prague, Czech Republic

Adaptive Clinical Trial: Translation in Action - How statistics can effectively couple clinical trials & personalised medicine in Oncology. Clinical trials run by pharmaceutical and biotech companies...

[Comment] Regulating clinical trials in Europe

Many medical researchers seem to agree that the European legislation on clinical trials needs to change. Between 2007 and 2011, the number of clinical trials started in Europe fell by 25%. Much critic...

Rising Number Of Clinical Trials Poses Significant Challenge For Insurers

Allianz Global Corporate & Specialty (AGCS) recently held its annual one-day Clinical Trials Conference, addressing a number of vital issues and challenges that the Life Science Industry and Insurance...

Rising Number Of Clinical Trials Poses Significant Challenge For Insurers�

Allianz Global Corporate & Specialty (AGCS) recently held its annual one-day Clinical Trials Conference, addressing a number of vital issues and challenges that the Life Science Industry and Insurance...

Should pharma companies outsource clinical trials?

Jeremy Spivey discusses the pros and cons of outsourcing clinical trials, looking at clinical strategies, patient recruitment and global challenges. A recent news story suggested that unnecessary cli...

WCCT Global, Verified Clinical Trials enhance clinical trials database registry

WCCT Global, a full service CRO supporting phase I-IV development, has collaborated with Verified Clinical Trials (VCT), the largest national clinical trials database registry in the U.S., to help the...

CTTI forms patient leadership council to drive improvements in clinical trials

 As part of an effort to improve the way clinical trials are conducted, the Clinical Trials Transformation Initiative (CTTI), a public-private partnership to identify practices to increase the qualit...

EC's Dalli comments on clinical trials in Europe

European Commissioner for Health and Consumer Policy John Dalli said he is "committed to introducing a legislative proposal" to revise the EU's clinical trials directive to make Europe more attractive...

Characterization of a functional C-terminus of the Mycobacterium tuberculosis MtrA responsible for both DNA binding and interaction with its two-component partner protein, MtrB.

Virulence in pathogenic bacteria is due in part to the action of two-component systems. However, in the human pathogen Mycobacterium tuberculosis, the molecular mechanisms underlying these systems are...

Solution-Based Structural Analysis of the Decaheme Cytochrome, MtrA, by Small-Angle X-ray Scattering and Analytical Ultracentrifugation.

The potential exploitation of metal-reducing bacteria as a means for environmental cleanup or alternative fuel is an exciting prospect; however, the cellular processes that would allow for these appli...

The characterization of conserved binding motifs and potential target genes for M. tuberculosis MtrAB reveals a link between the two-component system and the drug resistance of M. smegmatis.

ABSTRACT: BACKGROUND: The two-component systems of Mycobacterium tuberculosis are apparently required for its growth and resistance in hostile host environments. In such environments, MtrAB has been r...

Setting up a Respiratory Trials Unit.

Clinical trials are an essential in advancing our knowledge and treatment of patients with respiratory disease. Conducting well designed clinical studies which accurately and reliably answer important...

NHLBI clinical trials workshop: an executive summary.

On September 13-14, 2010, the National Heart, Lung and Blood Institute (NHLBI) organized a workshop: 'Clinical Trials: Past, Present and Future'. The workshop covered many areas in clinical trials, in...